CET Has Been Rewarded A Sole Source Navy Contract for Human Amniotic Mesenchymal Stem Cells.
November 3, 2017
CET announces that they are the recipient of a sole source navy contract for providing human amniotic mesenchymal stem cells. Terms of the contract are not disclosed. According to the contract, CET won a sole source military contract because its mesenchymal performed superior to other vendor's mesenchymal stem cells.